With cutting-edge design and interactivity, rely on a service that provides a fast, clear and detailed perspective of pharma analysis, forecasts and data.
Innovative data visualizations brings your research to life, helping you to quickly identify niche market trends and compare products, while event-driven research and integrated industry news headlines provide a view of the market as key trends and events unfold.
As the pharma industry evolves, it’s important to know you are basing your decisions on analysis that reflects the very latest trends and issues. With event-sensitive analysis, you can build your strategy based on analysis and forecasts that are reliable and accurate, to give you the tools to rapidly respond to changes across key diseases areas, companies and drugs.
Our new service integrates news powered by SCRIP, a trusted and well-established source of commentary, opinion and insights for the pharmaceutical industry. This exciting new addition will provide you with a uniquely holistic view of the industry, as our in-depth analysis becomes complemented by headlines and articles on fast-moving issues across regulation, product approvals and rejections and key corporate events. SCRIP’s team of editors and journalists don’t simply provide reaction to industry events, but assess the potential impact of breaking news stories and the implications they may have for products, markets and the competitive landscape.
You don’t always have time to seek out the latest content, which is why we’ve enhanced our Research Alerts to make them more relevant, more accessible and easier to use. Instead of navigating to a separate Tools section of the site, you’ll be able to arrange personalized updates while browsing a piece of research, without leaving the page. Simply choose from three different alert types, set the frequency, and wait for the research to land in your inbox.
Request demo Keeping pace with market developments has never been more important. See how our up-to-date research, analysis, opinion and news will allow you to respond to events even faster.
Not simply viewing analysis, but experiencing it through dynamic interactions that will help you to shape and visualize insights and fuel a richer knowledge and understanding of trends and issues.
We have invested in state-of-the-art data visualization software to give you the freedom to shape, manipulate and experiment with data in powerful new ways. Flexible functionality will introduce an entirely new level of personalization by enabling you to test, compare and experiment with scenarios and assumptions in compelling and informative visuals – fueling a far richer understanding of trends and issues.
Take a quick glimpse…
Our data visualization won’t be limited to disease analysis. We’ve responded to your overwhelmingly positive feedback about our Company and Drugs database – ‘the PharmaVitae Explorer’ – by integrating its functionality into the heart of our service.
This means that in-depth analysis of leading pharma and biotech companies will now be complemented by interactive sales, pipeline and financial data, all in the same place, giving you an integrated perspective of the company landscape.
Request demo Take a guided tour to see how our cutting edge data visualisation software will allow you to unlock insights and trends within complex data-sets at the touch of a button.
View the full breadth of the pharma market in clear and in-depth detail. You can only know the path ahead by seeing what’s in front of you, so survey your market horizons to identify the drugs, diseases or companies that matter.
Our design is framed around your view of the market, so whether you need to assess a company, compare products or require disease-specific insights, our service will show you the way.
Over 2,000 drugs have been tagged and extracted from across our portfolio to provide a complete perspective of a marketed product or pipeline compound across its full range of indications.
View detailed analysis of the pipelines, performances and future prospects for the Top 50 pharma companies and 29 emerging pharma/biotech companies at the forefront of innovation in the industry.
Market dynamics of 8 major disease areas and key indications to assess treatment trends, unmet needs and topical developments in addition to the pipeline and currently marketed products of key companies.
Examine disease prevalence and patient-population projections across key geographies to quantify unmet need potential, with forecasts based on rigorous data standards and methodologies.
Assess key trends shaping the industry and position your company to respond effectively to factors influencing pricing/reimbursement, competitive dynamics, growth markets and value chain issues.
The path to meaningful insights will become clearer, easier and quicker. We’ve taken extensive steps to improve the accessibility of our analysis, so that upon entering your service, you’re never more than three steps away from highly focused analysis that’s aligned to your requirements.
But accessibility is only part of the story. The new design and layout will also enable you to look across the breadth of our analysis at a glance, ensuring you always have the best perspective of available research within your focus area.
Our service isn’t just designed to provide a clear and simple path to research, but one that’s flexible too. Agile functionality will allow you to quickly change your view of analysis – so if you’re looking at a drug within a specific disease area, you can immediately flip across to view the full drug profile, or look at analysis within the context of other indications.
Request demo See how our research has been organised to match your view of the market so you can look across disease areas, strategic developments, epidemiological insights and leading companies with ease.
Closer means you’re not only reliant on research or data, but a quick request away from bespoke guidance and consultation from a wide range of experienced industry experts, as well as support from our client services team.
On some occasions, a personal touch can make all the difference.
Our re-launched Ask the Analyst service will ensure our team of experts are always on hand to provide additional guidance or bespoke support for issues that are specific to your business.
We’ll also collaborate with SCRIP’s team of experienced journalists to create solutions that are best-equipped to meet your requirements. Access entitlement varies based on your subscription – contact your Account Manager for further information.
Research can sometimes be a difficult terrain, but Client Services know their way around our service better than anyone. They have great tips on how to make the most of your analysis and will always be on hand to offer direction, advice or support. Our dedicated team aims to answer your queries within 24 hours and regularly hosts a variety of interactive webinars that will guide you through your research and demonstrate the applications of all your service features.
Request demo Meet your future team. Whether you have a technical enquiry, would like some advanced training, or have a specific market or company question, the team are on hand to respond to your needs.
You now have full access to all articles on our site for the next 28 days.